You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
|
---|---|
Published in |
ClinicoEconomics and Outcomes Research: CEOR, October 2013
|
DOI | 10.2147/ceor.s49279 |
Pubmed ID | |
Authors |
Onur Baser, Krishna Tangirala, Wenhui Wei, Lin Xie |
Abstract |
In patients with type 2 diabetes mellitus, basal-bolus strategies can improve treatment by offering dosing flexibility, and improved satisfaction, adherence, and clinical outcomes. The purpose of this study was to compare real-world outcomes between US patients initiating analog insulin therapy with insulin glargine and those initiating with a premixed analog insulin (PMX). |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 20% |
Italy | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 40% |
Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 19% |
Other | 6 | 17% |
Researcher | 6 | 17% |
Student > Doctoral Student | 3 | 8% |
Student > Bachelor | 3 | 8% |
Other | 7 | 19% |
Unknown | 4 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 31% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 17% |
Social Sciences | 3 | 8% |
Nursing and Health Professions | 2 | 6% |
Psychology | 2 | 6% |
Other | 5 | 14% |
Unknown | 7 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2013.
All research outputs
#14,739,222
of 25,942,066 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#258
of 530 outputs
Outputs of similar age
#114,446
of 221,180 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#6
of 15 outputs
Altmetric has tracked 25,942,066 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 530 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,180 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.